Location History:
- Florham Park, NJ (US) (2014 - 2015)
- Rahway, NJ (US) (2016)
Company Filing History:
Years Active: 2014-2016
Title: The Innovative Contributions of Wenlang Fu
Introduction
Wenlang Fu is a notable inventor based in Florham Park, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic methods and compounds. With a total of 3 patents, his work has had a considerable impact on the industry.
Latest Patents
One of Wenlang Fu's latest patents is titled "Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications." This invention aims to provide a method for the rapid evaluation of novel sugar modifications used in siRNA synthesis. It focuses on the rapid assessment of chemical modification patterns within siRNA to enhance stability and efficacy in siRNA therapeutics. Another significant patent is "Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors." This invention relates to novel compounds that can be used in pharmaceutical compositions for treating angiogenesis-related disorders, particularly those affecting ocular health.
Career Highlights
Throughout his career, Wenlang Fu has worked with prominent companies such as Sirna Therapeutics, Inc. and Bayer Intellectual Property GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in therapeutic technologies.
Collaborations
Wenlang Fu has collaborated with notable professionals in his field, including Gabor Butora and Ian W Davies. These collaborations have further enriched his research and development efforts, leading to impactful inventions.
Conclusion
Wenlang Fu's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic methods and compounds.